Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-07-28
2000-11-28
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514408, 514422, 514423, 514428, A61K 3140, A61K 31445, A61P 2500
Patent
active
061536245
ABSTRACT:
The present invention relates to the use of pyrrolidine and piperidine derivatives of the general formula ##STR1## wherein R.sup.1 and R.sup.2 are, independently from each other, hydrogen, lower alkoxy, hydroxy, halogen, --CONH.sub.2 or --C(O)O-lower alkyl; or taken together are --O--CH.sub.2 O;
REFERENCES:
patent: 3941796 (1976-03-01), Sankey et al.
patent: 4407670 (1983-10-01), Crabb
patent: 4548951 (1985-10-01), Muchowski et al.
patent: 4558066 (1985-12-01), Waterbury
Fischer et al., J. of Pharmacology & Expermental Therapeutics, 283, 1285-1292. (1997).
Kaiser et al., J. Org. Chem., 49, 4203-4209 (1984).
Aizenman E et al. Brain Res. 551(1-2), 355-7, 1991.
Alanine Alexander
Buttelmann Bernd
Heitz Neidhart Marie-Paule
Pinard Emmanuel
Wyler Rene
Hoffman-LaRoche Inc.
Huang Evelyn Mei
Johnston George W.
Tramaloni Dennis P.
LandOfFree
Pyrrolidine and piperidine derivatives and treatment of neurodeg does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine and piperidine derivatives and treatment of neurodeg, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine and piperidine derivatives and treatment of neurodeg will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726110